Company
Empatica
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
9
510(k), De Novo and PMA
Device trials
4
As lead sponsor, any status
Adverse event reports
1
Received Nov 1, 2025 to Nov 19, 2026
Recall records
1
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Empatica, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Empatica.
Latest FDA decisions
The 8 newest of 9 since 2015.
K260374 · Decided Aug 14, 2026 · 190 days after receipt
Device type: Transducer, Tremor (GYD) · Neurology & Neurosurgery
- EmbraceMini510(k)
K252981 · Decided Dec 22, 2025 · 96 days after receipt
Device type: Device, Sleep Assessment (LEL) · Neurology & Neurosurgery
- EpiMonitor510(k)
K250515 · Decided Jun 19, 2025 · 118 days after receipt
Device type: Physiological Signal Based Seizure Monitoring System (POS) · Neurology & Neurosurgery
K242737 · Decided Jun 6, 2025 · 268 days after receipt
Device type: Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms) (MWI) · Cardiology
- EpiMonitor510(k)
K232915 · Decided Feb 15, 2024 · 149 days after receipt
Device type: Physiological Signal Based Seizure Monitoring System (POS) · Neurology & Neurosurgery
K230457 · Decided Oct 30, 2023 · 251 days after receipt
Device type: Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms) (MWI) · Cardiology
K221282 · Decided Nov 20, 2022 · 201 days after receipt
Device type: Oximeter (DQA) · Cardiology
- Embrace510(k)
K181861 · Decided Dec 20, 2018 · 161 days after receipt
Device type: Physiological Signal Based Seizure Monitoring System (POS) · Neurology & Neurosurgery
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Forecasting Seizures Using Intelligent Wearable Technology for Health TrackingPivotal-lookingStatus unknown
NCT06275685 · 3,000 participants (planned) · Start Apr 11, 2024 · Primary completion Jun 2026
Device: SeizureWise algorithm; Multi-day Visualizations · For: Epilepsy; Seizure
Sites: Boston, Massachusetts
- EmbracePlus SpO2 Accuracy ValidationCompleted
NCT04964609 · 14 participants · Start Jun 16, 2021 · Primary completion Nov 21, 2022
Device: EmbracePlus · For: Oximetry
Sites: San Francisco, California
- Generalized Seizure Detection And Alerting In The EMU With The Empatica Embrace Watch And Smartphone-Based Alert SystemStatus unknown
NCT03207685 · 100 participants (planned) · Start Jun 30, 2017 · Primary completion Jan 15, 2019
Device: Additional Seizure Monitoring · For: Epilepsy
Sites: New York, New York; Roma, Italy
- Embrace: Seizure CharacterizationStatus unknown
NCT03206502 · 100,000 participants (planned) · Start May 2016 · Primary completion May 2026
Device: Embrace + Alert App · For: Epilepsy
Reports received
1
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
0.0% of reports
Injury reports
1
100% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 1 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 1 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0159-2024 · Started Jul 13, 2023 · Posted by FDA Oct 24, 2023
Reason given: May have a battery life lasting less than the full 48 hours, requiring the device to be charged more frequently.
Cause as FDA categorized it: Device Design · Device type: Physiological Signal Based Seizure Monitoring System (POS)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.